Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 105

1.

Pre-operative hypoalbuminemia is associated with complication rate and overall survival in patients with vulvar cancer undergoing surgery.

Bekos C, Polterauer S, Seebacher V, Bartl T, Joura E, Reinthaller A, Sturdza A, Horvat R, Schwameis R, Grimm C.

Arch Gynecol Obstet. 2019 Oct;300(4):1015-1022. doi: 10.1007/s00404-019-05278-7. Epub 2019 Aug 29.

2.

Interim analysis of a real-world precision medicine platform for molecular profiling of metastatic or advanced cancers: MONDTI.

Kieler M, Unseld M, Bianconi D, Waneck F, Mader R, Wrba F, Fuereder T, Marosi C, Raderer M, Staber P, Berger W, Sibilia M, Polterauer S, Müllauer L, Preusser M, Zielinski CC, Prager GW.

ESMO Open. 2019 Jul 17;4(4):e000538. doi: 10.1136/esmoopen-2019-000538. eCollection 2019.

3.

PET/MRI versus PET/CT in oncology: a prospective single-center study of 330 examinations focusing on implications for patient management and cost considerations.

Mayerhoefer ME, Prosch H, Beer L, Tamandl D, Beyer T, Hoeller C, Berzaczy D, Raderer M, Preusser M, Hochmair M, Kiesewetter B, Scheuba C, Ba-Ssalamah A, Karanikas G, Kesselbacher J, Prager G, Dieckmann K, Polterauer S, Weber M, Rausch I, Brauner B, Eidherr H, Wadsak W, Haug AR.

Eur J Nucl Med Mol Imaging. 2019 Aug 13. doi: 10.1007/s00259-019-04452-y. [Epub ahead of print]

PMID:
31410538
4.

Prognostic value of serum creatine level in patients with vulvar cancer.

Schwameis R, Postl M, Bekos C, Hefler L, Reinthaller A, Seebacher V, Grimm C, Polterauer S, Helmy-Bader S.

Sci Rep. 2019 Jul 31;9(1):11129. doi: 10.1038/s41598-019-47560-3.

5.

Low anterior resection syndrome (LARS) in patients with epithelial ovarian cancer after primary debulking surgery.

Kranawetter M, Ataseven B, Grimm C, Schneider S, Riss S, Alesina P, Prader S, Walz MK, Harpain F, Stift A, Heitz F, Reinthaller A, Polterauer S, Harter P, du Bois A.

Gynecol Oncol. 2019 Sep;154(3):577-582. doi: 10.1016/j.ygyno.2019.06.015. Epub 2019 Jun 21.

PMID:
31235241
6.

Gamma-glutamyltransferase as a preoperative differential diagnostic marker in patients with adnexal mass.

Reiser E, Aust S, Seebacher V, Reinthaller A, von Mersi H, Schwameis R, Polterauer S, Grimm C, Helmy-Bader S.

Eur J Obstet Gynecol Reprod Biol. 2019 Aug;239:16-20. doi: 10.1016/j.ejogrb.2019.05.031. Epub 2019 May 25.

PMID:
31158789
7.

NECTIN4 (PVRL4) as Putative Therapeutic Target for a Specific Subtype of High Grade Serous Ovarian Cancer-An Integrative Multi-Omics Approach.

Bekos C, Muqaku B, Dekan S, Horvat R, Polterauer S, Gerner C, Aust S, Pils D.

Cancers (Basel). 2019 May 20;11(5). pii: E698. doi: 10.3390/cancers11050698.

8.

Contralateral prophylactic mastectomy in women with breast cancer without a family history or genetic predisposition : Consensus statement from the Austrian Gynecologic Oncology Working Group of the Austrian Society of Obstetrics and Gynecology.

Bjelic-Radisic V, Singer C, Tamussino K, Kölbl H, Petru E, Volgger B, Polterauer S, Oppelt P, Sevelda P, Bogner G, Marth C; Austrian Gynecologic Oncology Working Group.

Wien Klin Wochenschr. 2019 May;131(9-10):233-236. doi: 10.1007/s00508-019-1468-7. Epub 2019 Mar 18.

PMID:
30887224
9.

Association between family history, mutation locations, and prevalence of BRCA1 or 2 mutations in ovarian cancer patients.

Singer CF, Tan YY, Muhr D, Rappaport C, Gschwantler-Kaulich D, Grimm C, Polterauer S, Pfeiler G, Berger A, Tea MM.

Cancer Med. 2019 Apr;8(4):1875-1881. doi: 10.1002/cam4.2000. Epub 2019 Mar 1.

10.

Lymph node ratio in inguinal lymphadenectomy for squamous cell vulvar cancer: Results from the AGO-CaRE-1 study.

Polterauer S, Schwameis R, Grimm C, Hillemanns P, Jückstock J, Hilpert F, de Gregorio N, Hasenburg A, Sehouli J, Fürst ST, Strauß HG, Baumann K, Thiel F, Mustea A, Harter P, Wimberger P, Kölbl H, Reinthaller A, Woelber L, Mahner S.

Gynecol Oncol. 2019 May;153(2):286-291. doi: 10.1016/j.ygyno.2019.02.007. Epub 2019 Feb 11.

PMID:
30760408
11.

The value of pretreatment serum butyrylcholinesterase level as a novel prognostic biomarker in patients with cervical cancer treated with primary (chemo-)radiation therapy.

Poetsch N, Sturdza A, Aust S, Polterauer S, Grimm C, Schwameis R, Pötter R, Koelbl H, Reinthaller A, Seebacher V.

Strahlenther Onkol. 2019 May;195(5):430-440. doi: 10.1007/s00066-019-01430-z. Epub 2019 Feb 8.

12.

Factors associated with post-relapse survival in patients with recurrent cervical cancer: the value of the inflammation-based Glasgow Prognostic Score.

Seebacher V, Sturdza A, Bergmeister B, Polterauer S, Grimm C, Reinthaller A, Hilal Z, Aust S.

Arch Gynecol Obstet. 2019 Apr;299(4):1055-1062. doi: 10.1007/s00404-018-4993-0. Epub 2018 Dec 10.

13.

Predictive and Prognostic Implication of Bowel Resections During Primary Cytoreductive Surgery in Advanced Epithelial Ovarian Cancer.

Bartl T, Schwameis R, Stift A, Bachleitner-Hofmann T, Reinthaller A, Grimm C, Polterauer S.

Int J Gynecol Cancer. 2018 Nov;28(9):1664-1671. doi: 10.1097/IGC.0000000000001369.

PMID:
30371563
14.

Conservative management of endometrial cancer: a survey amongst European clinicians.

La Russa M, Zapardiel I, Halaska MJ, Zalewski K, Laky R, Dursun P, Lindquist D, Sukhin V, Polterauer S, Biliatis I.

Arch Gynecol Obstet. 2018 Aug;298(2):373-380. doi: 10.1007/s00404-018-4820-7. Epub 2018 Jun 26.

PMID:
29943129
15.

Activity of Pembrolizumab in Recurrent Cervical Cancer: Case Series and Review of Published Data.

Kranawetter M, Röhrich S, Müllauer L, Obermair H, Reinthaller A, Grimm C, Sturdza A, Köstler WJ, Polterauer S.

Int J Gynecol Cancer. 2018 Jul;28(6):1196-1202. doi: 10.1097/IGC.0000000000001291.

PMID:
29787422
16.

Influence of age on histologic outcome of cervical intraepithelial neoplasia during observational management: results from large cohort, systematic review, meta-analysis.

Bekos C, Schwameis R, Heinze G, Gärner M, Grimm C, Joura E, Horvat R, Polterauer S, Polterauer M.

Sci Rep. 2018 Apr 23;8(1):6383. doi: 10.1038/s41598-018-24882-2.

17.

AB0 blood groups and rhesus factor expression as prognostic parameters in patients with epithelial ovarian cancer - a retrospective multi-centre study.

Seebacher V, Polterauer S, Reinthaller A, Koelbl H, Achleitner R, Berger A, Concin N.

BMC Cancer. 2018 Apr 19;18(1):447. doi: 10.1186/s12885-018-4289-6.

18.

Influence of training level on cervical cone size and resection margin status at conization: a retrospective study.

Montanari E, Grimm C, Schwameis R, Kuessel L, Polterauer S, Paternostro C, Husslein H.

Arch Gynecol Obstet. 2018 Jun;297(6):1517-1523. doi: 10.1007/s00404-018-4761-1. Epub 2018 Mar 30.

19.

A collagen-fibrin patch for the prevention of symptomatic lymphoceles after pelvic lymphadenectomy in women with gynecologic malignancies: A randomized clinical trial.

Grimm C, Polterauer S, Helmy-Bader S, Zikan M, Cibula D, Heitz F, Harter P, Giese A, Reinthaller A, Tempfer C.

Gynecol Oncol. 2018 Apr;149(1):140-145. doi: 10.1016/j.ygyno.2018.01.012. Epub 2018 Feb 12.

PMID:
29395308
20.

Prognostic role of plasma fibrinogen in patients with uterine leiomyosarcoma - a multicenter study.

Bekos C, Grimm C, Brodowicz T, Petru E, Hefler L, Reimer D, Koch H, Reinthaller A, Polterauer S, Polterauer M.

Sci Rep. 2017 Nov 3;7(1):14474. doi: 10.1038/s41598-017-13934-8.

Supplemental Content

Loading ...
Support Center